Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Biotech
GSK pays Flagship biotech $80M for preclinical neuro pact
GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius.
Gabrielle Masson
Nov 12, 2024 6:30am
GSK axes vaccine from $2.1B deal, switches to preclinical heir
Oct 30, 2024 7:06am
GSK aims to extend lupus dominance via $300M T-cell engager deal
Oct 29, 2024 8:00am
GSK and Cambridge scientists join forces in $65M immune R&D deal
Oct 22, 2024 3:30pm
GSK and Boston scientists team up to tackle lung diseases
Oct 18, 2024 11:26am
Wave hails human RNA editing first for GSK-partnered prospect
Oct 16, 2024 10:22am
